Bruker Corporation (BRKR)
BRKR moved a median of -0.10% 30 minutes after news, and +0.03% by the close. How BRKR actually reacts to news — the realized, point-in-time move the market made, measured across 395 labeled events over the last three years with zero look-ahead.
BRKR’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.11% | 46% | 395 |
| 30-min | -0.10% | 46% | 395 |
| 60-min | -0.15% | 45% | 395 |
| to close | +0.03% | 51% | 390 |
| Middle 50% of BRKR reactions | -1.00% to +0.83% |
|---|---|
| Median reaction (30-min) | -0.10% |
| Measured reactions | 395 |
Half of all Bruker Corporation news events land between -1.00% and +0.83% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How BRKR reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 15 | +1.49% | 73% | +0.19% |
| Analyst downgrades | 11 | +0.03% | 55% | -0.65% |
| Coverage initiations | 28 | +0.86% | 71% | -0.02% |
| Rating reiterations | 90 | -0.16% | 43% | -0.12% |
| Price-target raises | 12 | +0.17% | 67% | +0.44% |
| Price-target cuts | 30 | -0.16% | 43% | -0.68% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. See how BRKR ranks against every other measured name →
That’s how BRKR usually reacts — get an email when it moves on news →Email me when BRKR moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BRKR's baseline. Nothing else.
Recent BRKR events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution | Press release | Business Wire | +1.86% | -6.45% | |
| Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research | Press release | Business Wire | -0.32% | +0.10% | |
| Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley | Press release | Business Wire | -1.89% | -0.76% | |
| Bruker Corporation to Present at Upcoming Investor Conferences | Press release | Business Wire | +0.09% | +1.09% | |
| BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion | Press release | Business Wire | -1.20% | -1.38% | |
| Form 8-K BRUKER CORP For: Aug 14 | SEC filing · Form 8-K | SEC EDGAR | +0.69% | +0.77% | |
| Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories | Press release | Business Wire | -0.51% | +1.48% | |
| Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development | Press release | Business Wire | +1.62% | — | |
| Form 10-Q BRUKER CORP For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.21% | -0.21% | |
| Bruker Reports Second Quarter 2026 Financial Results | Press release | Business Wire | -0.83% | -7.11% | |
| Form 8-K BRUKER CORP For: Aug 04 | SEC filing · Form 8-K | SEC EDGAR | -0.83% | -7.11% | |
| Form 8-K BRUKER CORP For: Jul 30 | SEC filing · Form 8-K | SEC EDGAR | -0.63% | -2.81% | |
| Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast | Press release | Business Wire | -1.18% | -0.66% | |
| Bruker Expands Infection Detection Portfolio with Acquisition of Metagenomic mNGS DISQVER® Platform for Pathogenic Microorganisms in Blood | Press release | Business Wire | +0.38% | -2.64% | |
| Form S-3ASR BRUKER CORP | SEC filing · Form S-3ASR | SEC EDGAR | +0.27% | +3.42% | |
| Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026 | Press release | Business Wire | -1.02% | -6.03% | |
| Bruker Launches new timsMRMS Mass Spectrometry Platform for Unique Ultra-Complex Mixture Applications in the Energy Industry | Press release | Business Wire | -0.59% | +1.00% | |
| Bruker Announces Major Strides in 4D Proteomics Performance, Further Advances In Intact and Top-Down Functional Proteoform Analysis, and Innovations in Hybrid Qual/Quant 4D Metabolomics – all to Enable Deeper Insights into Disease Biology | Press release | Business Wire | +0.73% | +1.85% | |
| Form 8-K/A BRUKER CORP For: May 21 | SEC filing · Form 8-K | SEC EDGAR | +0.73% | +1.85% | |
| Form SD BRUKER CORP | SEC filing · Form SD | SEC EDGAR | +0.73% | +1.85% | |
| Champalimaud Foundation’s Neuroscience and Oncology Research Benefits from 18 Tesla Ultra-High Field MRI | Press release | Business Wire | -1.87% | +1.98% | |
| Form 8-K BRUKER CORP For: May 21 | SEC filing · Form 8-K | SEC EDGAR | +0.35% | +1.33% | |
| Form 8-K BRUKER CORP For: May 15 | SEC filing · Form 8-K | SEC EDGAR | -0.79% | -0.37% | |
| Form 10-Q BRUKER CORP For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -2.88% | -0.25% | |
| Bruker Reports First Quarter 2026 Financial Results | Press release | Business Wire | -2.59% | +1.03% | |
| Form 8-K BRUKER CORP For: May 06 | SEC filing · Form 8-K | SEC EDGAR | -2.59% | +1.03% | |
| Form 8-K BRUKER CORP For: Apr 28 | SEC filing · Form 8-K | SEC EDGAR | +1.87% | -4.99% | |
| Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast | Press release | Business Wire | +0.12% | +0.25% | |
| Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management | Press release | Business Wire | +0.06% | +1.57% | |
| Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 | Press release | Business Wire | +0.06% | +1.57% | |
| Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 | Press release | Business Wire | +0.06% | +1.57% | |
| Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026 | Press release | Business Wire | +0.44% | +4.30% | |
| Form 8-K BRUKER CORP For: Apr 10 | SEC filing · Form 8-K | SEC EDGAR | +0.44% | +4.30% | |
| Form ARS BRUKER CORP For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.44% | +4.30% | |
| Form DEF 14A BRUKER CORP For: May 21 | SEC filing · Form DEF | SEC EDGAR | +0.44% | +4.30% | |
| Form DEFA14A BRUKER CORP | SEC filing · Form DEFA14A | SEC EDGAR | +0.44% | +4.30% | |
| Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research | Press release | Business Wire | -0.11% | +0.11% | |
| Bruker Announces Appointment of Thierry Bernard to its Board of Directors | Press release | Business Wire | -0.97% | -1.50% | |
| Form 8-K BRUKER CORP For: Apr 01 | SEC filing · Form 8-K | SEC EDGAR | -0.97% | -1.50% | |
| PreOmics GmbH and Biognosys AG Prevail in U.S. Patent Challenge | Press release | Business Wire | -0.20% | +1.01% | |
| Form 10-K BRUKER CORP For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +1.43% | +1.50% | |
| Form S-8 BRUKER CORP | SEC filing · Form S-8 | SEC EDGAR | +1.43% | +1.50% | |
| Form S-8 POS BRUKER CORP | SEC filing · Form S-8 | SEC EDGAR | +1.43% | +1.50% | |
| Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR | Press release | Business Wire | -1.33% | -1.36% | |
| Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications | Press release | Business Wire | +0.72% | +0.18% | |
| Bruker Advances Functional Proteomics 2.0 with timsOmniTM Mass Spectrometry Proteoform Analysis for Deeper Insights into Disease Biology | Press release | Business Wire | +0.08% | +4.33% | |
| Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum | Press release | Business Wire | +0.08% | +4.33% | |
| Form 8-K BRUKER CORP For: Feb 20 | SEC filing · Form 8-K | SEC EDGAR | +0.08% | +4.33% | |
| Bruker Reports Fourth Quarter and Full Year 2025 Financial Results | Press release | Business Wire | -5.47% | -5.04% | |
| Form 8-K BRUKER CORP For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | -5.47% | -5.04% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BRKR section they belong to.
Where else BRKR is measured.
BRKR earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PAIN THERAPEUTICS (PTIE) | 397 | -0.01% | 41% |
| UROVANT SCIENCES LTD COMMON (UROV) | 397 | 0.00% | 49% |
| Neuronetics, Inc. (STIM) | 395 | -0.21% | 45% |
| Axogen, Inc. (AXGN) | 393 | -0.12% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Bruker Corporation's median reaction calculated?
Every labeled BRKR news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 395 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 46% of BRKR's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BRKR's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.